Vetbiologics provides veterinarians with extensive regenerative medicine capability including the ability to rapidly produce regenerative stem cells at the point-of-care. These regenerative cells have been well qualified and include mesenchymal stem cells or MSC’s. At the site of damaged or diseased tissue, MSC’s produce an array of bioactive factors that contribute to positive outcomes. These growth factors can promote new blood flow, inhibit scarring and stimulate host cells to form new functional tissue. In this light, MSC’s can be thought of as therapeutic protein factories that have extensive clinical use.